Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia in patients unable to reach cholesterol goals with the maximum tolerated dose of a statin Bempedoic acid (ETC-1002; Nilemdo) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications